Avandia
GSK’s Arixtra set for expanded licence
July 26, 2010Sales and Marketing Arixtra, Avandia, GlaxoSmithKline, rotarix
GlaxoSmithKline is set to receive a green light to use its anti-clotting drug Arixtra to prevent spontaneous superficial-vein thrombosis (SVT). …
GSK takes £1.58bn hit from legal disputes
July 16, 2010Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat
GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …
GSK accused of Avandia cover-up
July 14, 2010Sales and Marketing Avandia, GlaxoSmithKline, diabetes
The ongoing battle over GlaxoSmithKline’s diabetes drug Avandia has taken another turn with US senators accusing the company of a …
Avandia to face European safety review
July 12, 2010Sales and Marketing Avandia, GlaxoSmithKline, diabetes
GlaxoSmithKline’s type II diabetes drug Avandia, the subject of safety concerns since its launch in 2000, is to be reviewed …
Avandia probe deepens
June 29, 2010Sales and Marketing Avandia, GlaxoSmithKline, diabetes
GlaxoSmithKline has come under further scrutiny from the FDA after two new studies showed patients taking its troubled diabetes medication …
GSK hits back at Avandia safety probe
February 25, 2010Sales and Marketing Avandia, diabetes
GlaxoSmithKline has hit back at allegations from US Senators that its diabetes drug Avandia raises the risk of heart attacks, …
Reports raise fresh Avandia safety questions
February 23, 2010Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes
GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …
Avandia suffering less in Europe
December 10, 2007Sales and Marketing Avandia, diabetes
New research by market data company TNS Healthcare suggests that fewer patients are being taken off Avandia in Europe than …
Dwindling sales mean job cuts at GSK
October 25, 2007Sales and Marketing Avandia, diabetes
GlaxoSmithKline saw sales in its pharmaceutical division dip 2% in the third quarter, as falling demand for Avandia continued to …
Avandia scare casts doubt over its future for Alzheimer’s
June 13, 2007Sales and Marketing Avandia, diabetes, safety
New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …
